Home Biotech Stocks

Biotech Stocks

Latest

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

INSYS announces Progress on Spray Technology Products, CBD Pharmaceuticals

Blockhain Tech - December 18, 2018

Corbus Starts Phase III Study For Dermatomyositis, Provides Business Update

Blockhain Tech - December 18, 2018

BTG Issued With Rejection Confirmation For Elevair Coil System By The...

Blockhain Tech - August 10, 2018

Akcea and Ionis Just Got A Major Boost

ME Staff - May 11, 2018

For Diabetes Patients, Management Solutions Are As Critical As Medications

ME Staff - May 10, 2018

Here Is What Just Happened With Aveo Pharmaceuticals

ME Staff - May 9, 2018

Here’s What’s Moving SIGA and Novartis

ME Staff - May 2, 2018

Biotechnology Movers: Karyopharm Therapeutics Inc. and Regeneron Pharmaceuticals

ME Staff - May 1, 2018

Here’s What Just Happened At Allergan

ME Staff - April 30, 2018

Here’s Why The Immunogen News Is Important For The Company

ME Staff - April 27, 2018

12 3...146 Page 1 of 146

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Market Morning: Alexa Spying, Boeing Sensor History, Macron Spoils Scallop Dinner

April 11, 2019

ICC, AgraFlora to Bring Native Colombian Cannabis Strains to 39K Retail...

April 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.